Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epigenetics
Research
Epigenetic cancer drug duo packs punch against colorectal cancer
A DNMT inhibitor paired with an EZH2 inhibitor induced changes in cancer cells that would make them more vulnerable to the immune system.
Helen Floersh
Apr 1, 2024 3:20pm
Epigenetic silencing lasts in mice, Chroma-sponsored study shows
Feb 28, 2024 11:00am
Tune’s HBV therapy hits the right notes in cells and mice
Dec 7, 2023 2:05pm
Chroma bags $135M to bolster epigenetic-focused platform
Feb 28, 2023 6:10pm
CRISPR pioneer's Epic bags $55M to use tiny Cas for epigenetics
Jul 12, 2022 6:00am
Epizyme to trim workforce and pipeline in cost-cutting plan
Mar 1, 2022 1:14pm
